Friends of Cancer Research Applauds this Appointment and Thanks Dr. Rachel Sherman for Her Incredible Service December 17, 2018 – Washington, DC – Today, the U.S. Food and Drug Administration (FDA) announced that Dr. Amy Abernethy will replace Dr. Rachel Sherman as Principal Deputy Commissioner of Food and Drugs. Friends of Cancer Research (Friends) applauds…
WASHINGTON, DC – The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute’s (NCI) recent revision of its clinical trial protocol template to broaden eligibility criteria for cancer clinical trials. The protocol template was expanded to help increase the opportunity for participation in NCI-funded clinical trials…
Results to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 6, 2018 – Washington, DC – Friends of Cancer Research (Friends) is pleased to announce that the results of Phase I of the tumor mutational burden (TMB) Harmonization Project will be presented as a late-breaking abstract at the Society…
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds Senators Orrin Hatch (R-UT) and Michael Bennet (D-CO) for responding to a recently identified public health issue and swiftly proposing a solution to an issue impacting patients and their physicians…
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization team finalizes data collected from the Phase I in silico analysis. “Recent data shows a role for TMB in identifying patients more likely…
August 9, 2018 – WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the Food and Drug Administration (FDA) recommended language for five guidance documents on ways to broaden eligibility criteria for cancer clinical trials. The recommendations are part of an ASCO and Friends…
New Data Supporting Use of Real-World Evidence Presented with Six Data Partners as well as FDA July 10, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) released the results of a unique pilot project at its event, The Future Use of Real-World Evidence. Data was compiled from six data partners regarding patients…
June 11, 2018 – Washington, DC – On Friday, June 8, 2018, The New York Times published an editorial titled “Easier Drug Approval Isn’t Cutting Drug Prices.” In it, The Times Editorial Board claims the FDA is lowering standards by working to get treatments to patients more quickly and instituting a “less regulation” approach to…
“Cancer patients cannot afford logistical delays and the OCE was not established to add another layer of bureaucracy.” – Ellen Sigal Washington, DC – March 14, 2018 – On Thursday, March 15, 2018, the U.S. Food and Drug Administration (FDA) will hold a public listening session on the Oncology Center of Excellence (OCE) from 9am…
WASHINGTON, DC, November 13, 2017 – Today, President Trump nominated Alex Azar to be the next Health and Human Services (HHS) Secretary. As the former head of one of our nation’s largest employers, Azar understands the multifaceted challenges that a Secretary may face. He previously served as Deputy HHS Secretary and HHS Chief Counsel under…
